Table of Content

1 Biologics and Biosimilars Market Introduction and Overview
1.1 Biologics and Biosimilars Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer
2.2 Manufacturers Biologics and Biosimilars Production Sites, Area Served, Product Types
2.3 Biologics and Biosimilars Market Competitive Situation and Trends
2.3.1 Biologics and Biosimilars Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Roche
3.1.1 Roche Company Profile
3.1.2 Biologics and Biosimilars Product Overview
3.1.3 Roche Biologics and Biosimilars Market Performance (2019-2024)
3.1.4 Roche Business Overview
3.2 Amgen
3.2.1 Amgen Company Profile
3.2.2 Biologics and Biosimilars Product Overview
3.2.3 Amgen Biologics and Biosimilars Market Performance (2019-2024)
3.2.4 Amgen Business Overview
3.3 AbbVie
3.3.1 AbbVie Company Profile
3.3.2 Biologics and Biosimilars Product Overview
3.3.3 AbbVie Biologics and Biosimilars Market Performance (2019-2024)
3.3.4 AbbVie Business Overview
3.4 Sanofi-Aventis
3.4.1 Sanofi-Aventis Company Profile
3.4.2 Biologics and Biosimilars Product Overview
3.4.3 Sanofi-Aventis Biologics and Biosimilars Market Performance (2019-2024)
3.4.4 Sanofi-Aventis Business Overview
3.5 Johnson & Johnson
3.5.1 Johnson & Johnson Company Profile
3.5.2 Biologics and Biosimilars Product Overview
3.5.3 Johnson & Johnson Biologics and Biosimilars Market Performance (2019-2024)
3.5.4 Johnson & Johnson Business Overview
3.6 Pfizer
3.6.1 Pfizer Company Profile
3.6.2 Biologics and Biosimilars Product Overview
3.6.3 Pfizer Biologics and Biosimilars Market Performance (2019-2024)
3.6.4 Pfizer Business Overview
3.7 Novo Nordisk
3.7.1 Novo Nordisk Company Profile
3.7.2 Biologics and Biosimilars Product Overview
3.7.3 Novo Nordisk Biologics and Biosimilars Market Performance (2019-2024)
3.7.4 Novo Nordisk Business Overview
3.8 Eli Lilly
3.8.1 Eli Lilly Company Profile
3.8.2 Biologics and Biosimilars Product Overview
3.8.3 Eli Lilly Biologics and Biosimilars Market Performance (2019-2024)
3.8.4 Eli Lilly Business Overview
3.9 Novartis
3.9.1 Novartis Company Profile
3.9.2 Biologics and Biosimilars Product Overview
3.9.3 Novartis Biologics and Biosimilars Market Performance (2019-2024)
3.9.4 Novartis Business Overview
3.10 Merck
3.10.1 Merck Company Profile
3.10.2 Biologics and Biosimilars Product Overview
3.10.3 Merck Biologics and Biosimilars Market Performance (2019-2024)
3.10.4 Merck Business Overview
4 Global Biologics and Biosimilars Historical and Forecast Market Analysis by Type
4.1 Global Biologics and Biosimilars Revenue and Market Share by Type
4.2 Global Biologics and Biosimilars Revenue Market Forecast by Type (2024-2030)
5 Global Biologics and Biosimilars Historical and Forecast Market Analysis by Application
5.1 Global Biologics and Biosimilars Revenue Market Share by Application (2019-2024)
5.2 Biologics and Biosimilars Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2 Biologics and Biosimilars Growth Trends Analysis by Regions
6.2.1 Biologics and Biosimilars Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Biologics and Biosimilars Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Biologics and Biosimilars Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.5 Europe Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.6 China Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.7 Japan Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.8 Korea Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.10 India Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.11 South America Biologics and Biosimilars Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Biologics and Biosimilars Market Size & Forecast (2019-2030)
7 North America
7.1 North America Biologics and Biosimilars Revenue by Players
7.2 North America Biologics and Biosimilars Revenue by Types
7.3 North America Biologics and Biosimilars Revenue by Applications
7.4 North America Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Biologics and Biosimilars Revenue by Players
8.2 Europe Biologics and Biosimilars Revenue by Types
8.3 Europe Biologics and Biosimilars Revenue by Applications
8.4 Europe Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Biologics and Biosimilars Revenue by Players
9.2 China Biologics and Biosimilars Revenue by Types
9.3 China Biologics and Biosimilars Revenue by Applications
9.4 China Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Biologics and Biosimilars Revenue by Players
10.2 Japan Biologics and Biosimilars Revenue by Types
10.3 Japan Biologics and Biosimilars Revenue by Applications
10.4 Japan Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Biologics and Biosimilars Revenue by Players
11.2 Korea Biologics and Biosimilars Revenue by Types
11.3 Korea Biologics and Biosimilars Revenue by Applications
11.4 Korea Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Biologics and Biosimilars Revenue by Players
12.2 Southeast Asia Biologics and Biosimilars Revenue by Types
12.3 Southeast Asia Biologics and Biosimilars Revenue by Applications
12.4 Southeast Asia Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Biologics and Biosimilars Revenue by Players
13.2 India Biologics and Biosimilars Revenue by Types
13.3 India Biologics and Biosimilars Revenue by Applications
13.4 India Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Biologics and Biosimilars Revenue by Players
14.2 South America Biologics and Biosimilars Revenue by Types
14.3 South America Biologics and Biosimilars Revenue by Applications
14.4 South America Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Biologics and Biosimilars Revenue by Players
15.2 Middle East & Africa Biologics and Biosimilars Revenue by Types
15.3 Middle East & Africa Biologics and Biosimilars Revenue by Applications
15.4 Middle East & Africa Biologics and Biosimilars Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Biologics and Biosimilars Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Biologics and Biosimilars Industrial Chain Analysis
17 Biologics and Biosimilars Industry Dynamic Analysis
17.1 Biologics and Biosimilars Market Trends Analysis
17.2 Biologics and Biosimilars Market Drivers Analysis
17.3 Biologics and Biosimilars Market Challenges Analysis
17.4 Biologics and Biosimilars Market Restraints Analysis
18 Research Findings and Conclusion